SCN5A and breast cancer: These results complement earlier data from human breast cancer, where nNav1.5 is again dominant, showing that, compared with low-level expression, patients with high levels of (n)Nav1.5 mRNA expression have (i) higher levels of disease recurrence and (i) shorter lifespans [41].